HIGHLIGHTS OF PRESCRIBING INFORMATION These
... Serious adverse reactions occurred in 19% of patients; the most frequently reported serious adverse reactions were pulmonary embolism (1.2%), dyspnea (1.2%), and hyperbilirubinemia (1.2%). Fatal adverse reactions occurred in 2.8% of patients and included hemorrhage (0.8%), intestinal perforation (0. ...
... Serious adverse reactions occurred in 19% of patients; the most frequently reported serious adverse reactions were pulmonary embolism (1.2%), dyspnea (1.2%), and hyperbilirubinemia (1.2%). Fatal adverse reactions occurred in 2.8% of patients and included hemorrhage (0.8%), intestinal perforation (0. ...
(PowerPoint)
... the corresponding Activity Survey questions on this form (slides will be marked as “Polling Questions” throughout the deck) ...
... the corresponding Activity Survey questions on this form (slides will be marked as “Polling Questions” throughout the deck) ...
Gabapentin Fact Sheet - The Main Line Center for the Family
... handout concerning drug dosages, schedules, routes of administration, and side effects is accurate as of the time of publication and consistent with standards set by the U.S. Food and Drug Administration and the general medical community and accepted psychiatric practice. This handout does not cover ...
... handout concerning drug dosages, schedules, routes of administration, and side effects is accurate as of the time of publication and consistent with standards set by the U.S. Food and Drug Administration and the general medical community and accepted psychiatric practice. This handout does not cover ...
prescribing information
... more antiepileptic drug). Therefore, the small increased risk of suicidal ideation and behavior reported from the metanalysis (0.43% for patients on antiepileptic drugs compared to 0.24% for patients on placebo) is based largely on patients that received monotherapy treatment (antiepileptic drug or ...
... more antiepileptic drug). Therefore, the small increased risk of suicidal ideation and behavior reported from the metanalysis (0.43% for patients on antiepileptic drugs compared to 0.24% for patients on placebo) is based largely on patients that received monotherapy treatment (antiepileptic drug or ...
DBL Dexamethasone Sodium Phosphate
... Replacement Therapy - Adrenocortical Insufficiency Dexamethasone has predominantly glucocorticoid activity and therefore is not a complete replacement therapy. It should be supplemented with salt and or a mineralocorticoid. When so supplemented dexamethasone is indicated in: ...
... Replacement Therapy - Adrenocortical Insufficiency Dexamethasone has predominantly glucocorticoid activity and therefore is not a complete replacement therapy. It should be supplemented with salt and or a mineralocorticoid. When so supplemented dexamethasone is indicated in: ...
Perchloracap - Nuclear Education Online
... Impairment Of Fertility No long-term animal studies have been performed to evaluate carcinogenic or mutagenic potential of potassium perchlorate. No adverse effects of potassium perchlorate on fertility have been reported. ...
... Impairment Of Fertility No long-term animal studies have been performed to evaluate carcinogenic or mutagenic potential of potassium perchlorate. No adverse effects of potassium perchlorate on fertility have been reported. ...
ketamine - Yorkshire and the Humber Deanery
... given advance notice of at least a week so that the drug may be ordered. The patient should be given an information leaflet about Ketamine that should include on it who they should contact in the event of any problems ...
... given advance notice of at least a week so that the drug may be ordered. The patient should be given an information leaflet about Ketamine that should include on it who they should contact in the event of any problems ...
viva question
... 2. Serious reported toxicities that is life threatening seizures and arrhythmias without any warning sign 3. Known correlation between serum level and toxicity 4. Significant inter patient variability in drug clearance known factors that may alter the clearance ...
... 2. Serious reported toxicities that is life threatening seizures and arrhythmias without any warning sign 3. Known correlation between serum level and toxicity 4. Significant inter patient variability in drug clearance known factors that may alter the clearance ...
NEWER DRUGS IN ANAESTHESIA Review Article (Medical Science)
... 200:11. The drug is licensed for the treatment of hypertension, migraine and menopausal flushing7. It is also an analgesic, sedative and anxiolytic. These properties along with its ability to maintain perioperative hemodynamic stability make clonidine a useful ag ...
... 200:11. The drug is licensed for the treatment of hypertension, migraine and menopausal flushing7. It is also an analgesic, sedative and anxiolytic. These properties along with its ability to maintain perioperative hemodynamic stability make clonidine a useful ag ...
Amerge Tablets
... reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours following administration of AMERGE. Some of these reactions occurred in patients without known CAD. AMERGE may cause coronary artery vasospasm (Prinzmetal’s angina) even in patients with ...
... reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours following administration of AMERGE. Some of these reactions occurred in patients without known CAD. AMERGE may cause coronary artery vasospasm (Prinzmetal’s angina) even in patients with ...
TRAMADOL Synonyms Description
... sedation, miosis and respiratory depression. The infant recovered following treatment with naloxone, benzodiazepines and ventilation. Adults A 47-year-old ingested 3,000 mg and was found unresponsive. He responded to IV naloxone but required intubation at hospital. EKG showed changes suggestive of B ...
... sedation, miosis and respiratory depression. The infant recovered following treatment with naloxone, benzodiazepines and ventilation. Adults A 47-year-old ingested 3,000 mg and was found unresponsive. He responded to IV naloxone but required intubation at hospital. EKG showed changes suggestive of B ...
Received: 08 Nov-2012 Revised: 14 Nov-2012 Accepted
... medicinal values of plants by exploration of existing scientific knowledge, traditional uses and discovery of potential chemotherapeutic agents. Phytochemicals are used as templates for lead optimization programs, which are intended to make safe and effective drugs (Hedge et al., 1990).The genus Cle ...
... medicinal values of plants by exploration of existing scientific knowledge, traditional uses and discovery of potential chemotherapeutic agents. Phytochemicals are used as templates for lead optimization programs, which are intended to make safe and effective drugs (Hedge et al., 1990).The genus Cle ...
Prevention and monitoring of the side effects of chronic
... decreased comparing to those without adverse events (7). In the other study, elderly people had decreased corticoid clearance (8): for that reason it is necessary to lower GCS doses in this group of patients. Comorbidities also affects the metabolism of GCS. The most important include: Hyperthyroidi ...
... decreased comparing to those without adverse events (7). In the other study, elderly people had decreased corticoid clearance (8): for that reason it is necessary to lower GCS doses in this group of patients. Comorbidities also affects the metabolism of GCS. The most important include: Hyperthyroidi ...
File
... modulation (contd.) Stimulation of small fiber input inhibits cells in SG and "open the gate". An open gate increases the stimulation of 2nd order neuron cells & increases transmission of impulses and enhances pain perception In addition to gate control through large and small fibers stimulation ...
... modulation (contd.) Stimulation of small fiber input inhibits cells in SG and "open the gate". An open gate increases the stimulation of 2nd order neuron cells & increases transmission of impulses and enhances pain perception In addition to gate control through large and small fibers stimulation ...
Document
... Based on data from inhaled budesonide and the fact that budesonide exhibits linear PK properties within the therapeutic dosage intervals after inhaled, oral and rectal administrations, at therapeutic doses of budesonide, exposure to the suckling child is anticipated to be low. These data support con ...
... Based on data from inhaled budesonide and the fact that budesonide exhibits linear PK properties within the therapeutic dosage intervals after inhaled, oral and rectal administrations, at therapeutic doses of budesonide, exposure to the suckling child is anticipated to be low. These data support con ...
An alpha-adrenergic agonist, clonidine functions as an antagonist at
... BACKGROUND: An alpha-adrenergic agonist, clonidine functions as an antagonist at receptors on cells of the locus ceruleus (found in the primitive pons) and is widely used to treat explosive symptoms in children,1 is effective in the treatment of combat-related post-traumatic stress disorder 2 and is ...
... BACKGROUND: An alpha-adrenergic agonist, clonidine functions as an antagonist at receptors on cells of the locus ceruleus (found in the primitive pons) and is widely used to treat explosive symptoms in children,1 is effective in the treatment of combat-related post-traumatic stress disorder 2 and is ...
Product information - zizhu
... Take one yellowish tablet marked the same date on the aluminium foil on Day 1 of your menstrual cycle. For example, if the onset of menstruation occurs on Wednesday, take one yellowish tablet marked Wednesday on the back of blister. Then take one tablet daily according to the arrow. After finishing ...
... Take one yellowish tablet marked the same date on the aluminium foil on Day 1 of your menstrual cycle. For example, if the onset of menstruation occurs on Wednesday, take one yellowish tablet marked Wednesday on the back of blister. Then take one tablet daily according to the arrow. After finishing ...
medications used in the management of substance use disorders
... Monitoring, Referrals, and Warnings: Specialty consultation advised. Baseline evaluation include: naloxone challenge test, transaminase levels and urine toxicology. Therapy is most effective when the patient is engaged in addiction-focused counseling with monitored administration. Repeat transaminas ...
... Monitoring, Referrals, and Warnings: Specialty consultation advised. Baseline evaluation include: naloxone challenge test, transaminase levels and urine toxicology. Therapy is most effective when the patient is engaged in addiction-focused counseling with monitored administration. Repeat transaminas ...
Atypical methotrexate ulcerative stomatitis with features of
... useful in predicting oral ulceration (3,4). The LDMTX-associated oral ulcers may be apparent within the first few weeks, whereas in long-term toxicity the lesions can occur even years later in the disease course (2). MTX metabolism may be affected by age, compromised hepatic or renal function, where ...
... useful in predicting oral ulceration (3,4). The LDMTX-associated oral ulcers may be apparent within the first few weeks, whereas in long-term toxicity the lesions can occur even years later in the disease course (2). MTX metabolism may be affected by age, compromised hepatic or renal function, where ...
AZOPT ® Suspension
... Nursing Women: AZOPT* should not be used by women nursing neonates/infants. It is not known whether topical AZOPT* is excreted in human milk; however, a risk to the nursing child cannot be excluded. In a study of brinzolamide in lactating rats, decreases in body weight gain in offspring at an oral ...
... Nursing Women: AZOPT* should not be used by women nursing neonates/infants. It is not known whether topical AZOPT* is excreted in human milk; however, a risk to the nursing child cannot be excluded. In a study of brinzolamide in lactating rats, decreases in body weight gain in offspring at an oral ...
PRODUCT MONOGRAPH ARGATROBAN (argatroban for injection
... The adverse events reported in this section are consistent with those which would be anticipated for a severely-ill patient population who present with HIT/HITTS syndrome. In general, these patients had a mean age of 60+ years and were on complex concomitant medications. No clinically significant sa ...
... The adverse events reported in this section are consistent with those which would be anticipated for a severely-ill patient population who present with HIT/HITTS syndrome. In general, these patients had a mean age of 60+ years and were on complex concomitant medications. No clinically significant sa ...
Anticoagulation Related Bleeding
... haematoma after a clear head injury should have their INR reversed with PCC dose eg 25u/kg immediately and before the CT and INR results are available. Delayed intracranial bleeding can occur in patients on warfarin even when the initial CT scan is normal. In view of this, patients with a supra-th ...
... haematoma after a clear head injury should have their INR reversed with PCC dose eg 25u/kg immediately and before the CT and INR results are available. Delayed intracranial bleeding can occur in patients on warfarin even when the initial CT scan is normal. In view of this, patients with a supra-th ...
Anti-inflammatory, Antirheumatoid and Related Agents
... Salicylates are NOT to be given to children under age 12 because of the risk of Reye’s syndrome. Because these agents generally cause GI distress, they are often better tolerated if taken with food, milk or an antacid to avoid GI irritation. Explain to patients that therapeutic effects may not be se ...
... Salicylates are NOT to be given to children under age 12 because of the risk of Reye’s syndrome. Because these agents generally cause GI distress, they are often better tolerated if taken with food, milk or an antacid to avoid GI irritation. Explain to patients that therapeutic effects may not be se ...
Epilim (Sodium Valproate)
... Liver function should be measured before and then periodically monitored during the first 6 months of therapy, especially in those who seem most at risk, and those with a prior history of liver disease. Amongst usual investigations, tests which reflect protein synthesis, particularly prothrombin rat ...
... Liver function should be measured before and then periodically monitored during the first 6 months of therapy, especially in those who seem most at risk, and those with a prior history of liver disease. Amongst usual investigations, tests which reflect protein synthesis, particularly prothrombin rat ...
PDF
... patients. These patients should commence the treatment with the lowest available dose. For these patients and for patients who require concomitant treatment with low-dose acetylsalicylic acid or other drugs likely to increase gastrointestinal risk, a combination therapy with gastric protective agent ...
... patients. These patients should commence the treatment with the lowest available dose. For these patients and for patients who require concomitant treatment with low-dose acetylsalicylic acid or other drugs likely to increase gastrointestinal risk, a combination therapy with gastric protective agent ...
Dydrogesterone
Dydrogesterone (INN, USAN, BAN), is also chemically known as 9β,10α-pregna-4,6-diene-3,20-dione. Dydrogesterone (6-dehydro-retroprogesterone) is a hormonally active, non-androgenic steroid that was developed in the 1950s.Dydrogesterone has selective progestational activity and does not inhibit ovulation. The greater rigidity of dydrogesterone also positively affects its selectivity, while natural progesterone is less selective, existing in different conformations that more easily bind to different receptors. As a consequence of its better bioavailability and the progestational activity of its main metabolites (20-, 21- and 16-hydroxy derivatives), the equivalent dose of dydrogesterone is 10–20 times lower than that of oral micronized progesterone.Dydrogesterone is used as an effective, orally active progestogen for gynaecological conditions related to a wide variety of progesterone deficiencies in pregnant women. The molecular structure and pharmacological effects are somewhat similar to endogenous progesterone, although in smaller amounts it is found to be orally active. Its freedom from hormonal effects like those related to corticoid, androgenic, estrogenic, anabolic, and other effects gives dydrogesterone an advantage over other synthesized progestogens.Dydrogesterone when used therapeutically is closely related to its physiological action on the neuro-endocrine control of ovarian function, as well as on the endometrium. This is an indication in all cases of endogeneous progesterone deficiency - relative or absolute. The molecule was licensed for use in several indications, including threatened or recurrent miscarriage, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhoea, irregular cycles, pre-menstrual syndrome and also as a hormone replacement therapy.Dydrogesterone has proven effective in the following conditions associated with progesterone deficiency: Infertility due to luteal insufficiency Threatened miscarriage Habitual or recurrent miscarriage. Menstrual disorders Premenstrual syndrome Endometriosis Dydrogesterone has also been registered as hormone replacement therapy (HRT) to counter-check the negative effects of unopposed estrogen on the endometrium in women with an intact uterus. Dydrogesterone is relatively safe and well tolerated, and does not exhibit the androgenic side effects that are common with some other progestins, like medroxyprogesterone acetate.